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Abstract 
In this paper we investigate the emission and detection characteristics of prompt gamma (PG) rays for in vivo range verification 
during hadron therapy, using Geant4 simulations. Proton, 4He and 12C beams of varying energy are incident on water phantoms. 
The PG production yield, energy spectral characteristics and spatial correlation with the Bragg Peak (BP) have been quantified. 
Further, the angular distributions for PG detection with respect to a point-of-reference on the phantom surface have been explored. 
The temporal properties of PG emission and time-of-flight (TOF) of PG detection have also been investigated in correlation with 
the changing particle beam range. Our results show that the primary PG rays from nuclear interactions of the primary beam exhibit 
the closest correlation to the beam range but its signal is significantly masked by the concurrent secondary PG rays, particularly 
for heavier ions such as carbon ion beams. The PG TOF spectroscopy encodes the essential information of the beam range but 
requires high time resolution measurements to retrieve it. A hybrid PG detection system to utilize the energy, timing and spatial 
characteristics of PG rays is desirable for BP tracking in real-time. 
Keywords: Prompt Gamma, Range Verification, Bragg Peak Tracking, Hadron Therapy, Time-of-Flight 
 
1. Introduction 
The goal of radiation therapy is to deliver highly localized treatment dose to kill cancer cells in the tumor volume while protecting 
the surrounding healthy tissue from radiation damage as much as possible. Hadron therapy (HT), based on charged particle beams 
such as proton (1H), helium (4He) and carbon (12C), offers unique benefits for cancer treatment over conventional photon therapy 
[1]. Most of the energy from hadron beams is deposited in the sharp and narrow Bragg Peak (BP) at the end of their range, which 
allows for a precise local dose distribution in the target tumor volume while minimizing the overspill of radiation on the healthy 
tissue. An additional advantage of HT is the enhanced relative biological effectiveness (RBE) of heavy ions, which is particularly 
beneficial for the treatment of radio-resistant or pediatric tumors [2]. However, the ability to fully exploit the advantages of HT is 
still limited by various uncertainties in predicting and determining the beam’s range in the traversed tissues [3]. The beam range 
uncertainties significantly affect the achievable treatment precision and lead to clinical applications with conservative safety 
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margins [4]. In vivo range verification and dose monitoring in real-time are desired to ensure high quality HT treatment, but such 
experimental tools remain unavailable in clinical routine. 
The promising strategy for in vivo beam range verification is to make use of the by-products of secondary penetrating radiations 
that occur during irradiations since the primary beam is absorbed inside the patient, such as interaction vertex imaging (IVI) [5], 
secondary electron bremsstrahlung (SEB) [6], thermoacoustic waves [7] and high energy gamma rays produced by hadronic beam 
interactions with tissue nuclei [8]. Over the past decades, significant research efforts have been undertaken worldwide to develop 
in vivo beam range verification techniques using the secondary radiation emission of gamma rays [9,10]. Positron emission 
tomography (PET) has been adopted for HT monitoring in clinical application. It relies on detecting and imaging the positron-
annihilation photons occurring from the decay of positron emitters created as a result of beam nuclear interactions with tissue 
nuclei [11-13]. However, the delayed decay of the short-lived radioisotopes, on the order of 1-20 minutes with respect to the 
irradiation, presents a major limitation for beam range verification in real-time. The quantitative accuracy of beam range 
verification from PET is also limited by a relatively low photon yield, the positron range effect and the biological washout effect. 
Furthermore, the production of the PET isotopes does not occur within the BP and requires some form of deconvolution to 
reconstruct the BP. On the other hand, the emission of prompt gamma (PG) rays from the decay of excited nuclear reaction products 
takes place almost instantaneously with the beam irradiation, thus allowing for BP tracking in real-time during treatment delivery 
with no washout effect [14]. The PG signal has been considered as the most desirable means for real-time in vivo range verification. 
However, the PG signal is largely masked by the concurrent emission of secondary PG rays resulting from the nuclear reactions 
undergone by the secondary particles/fragments created along the primary ion beam path, which could affect the accuracy of the 
BP tracking. This effect would be more pronounced with heavier ion species such as carbon beams with higher energies. 
PG emissions present several distinctive characteristics in space, energy and timing that have been proposed for in vivo range 
verification. The methods and feasibility of employing PG rays for beam range verification have been intensively studied for proton 
[15,16] and carbon beams [17,18], and recently reviewed in [19]. Helium ions for HT have gained increasing interest for clinical 
applications as the recent dosimetry characteristics studies of helium ions show that it could offer a more conformal treatment and 
in turn increase tumor control [20-22]. However, the PG emission characteristics from helium irradiation have not yet been widely 
studied [23]. The spatial correlation between PG rays and the depth dose profile has resulted in PG imaging (PGI) methods, 
including mechanical collimation such as slit cameras [24-26] and electronic collimation such as Compton cameras [27-29]. Recent 
clinical trials with the IBA knife-edge slit camera on patients [30,31] demonstrated that millimeter-level accuracy is achievable. 
Xie et al 2017 [31] demonstrated that PGI for in vivo proton beam range verification in actively delivered pencil beam scanning 
(PBS) on spot-by-spot tracking is feasible. However, the count statistics is still one of the main issues in such systems to achieve 
higher statistical precision of in vivo beam range verification. The slit camera based system can only provide one-dimensional 
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range information in the longitudinal beam direction but lacks the lateral spread information. Compton cameras could offer the 
possibility to perform 2D or 3D imaging but suffer high technological challenges in detectors and image reconstruction to achieve 
clinically acceptable images [32]. Other methods based on specific counting to utilize either the characteristic PG spectroscopy 
(PGS) [33,34], PG timing (PGT) [35] or PG peak integration (PGPI) [36], have recently been proposed as alternatives to the PGI. 
These non-imaging approaches have an advantage with low footprint detector setup in clinical practice. Each of these methods has 
its own advantages and shortcomings. Hybrid PG detection methods may be necessary to overcome the challenges of a broad- and 
high-energy distribution, a large background, high instantaneous count rates, and compatibility constraints with patient irradiation. 
This requires systematical studies of the PG characteristics in space, energy and time. 
A recent breakthrough of clinical prototype for proton range verification has been reported from the Massachusetts General 
Hospital (MGH) group [37]. It utilized energy- and time-resolved spectral measurements of PG rays with slit collimation and 
integrated with a Monte Carlo simulation based treatment planning system. The system can verify the absolute range of proton 
pencil beams with high spatial precision (1.1 mm) in phantoms under realistic clinical conditions. However, in this approach the 
temporal PGT information was only used to reject the gamma ray background from proton-induced and neutron-induced continua. 
The PGT information could be further utilized with hybrid PG detection systems for beam range verification. 
In this work, we focus on investigating the global properties of PG ray emission and propagation in a water phantom for in vivo 
range verification in HT for three different ion species: protons, helium and carbon ions. The PG production and detectable yields, 
and its emission distribution relationship with the dose distribution are quantified as a function of ion beam energies. The temporal 
properties of PG emission and time-of-flight (TOF) for detection are also explored to characterize the associated correlation with 
the changing particle beam range. This study not only compares the three ion species relevant to HT applications but also aims to 
optimize detection parameters, presenting also several quantitative data of PG emission and global detection. Hence, this paper 
will provide valuable information for designing an optimal PG detector system to allow accurate and efficient PG measurements 
for in vivo beam range monitoring in real-time. 
 
2. Methods 
The Geant4 Monte Carlo Toolkit [38-40] (version 10.02 patch 02) was used to investigate the characteristic emission of PG rays 
from the particle beams under study, incident on a homogeneous water phantom (density of 1 g/cm3). The set-up of the simulation 
is shown in Figure 1. Mono-energetic pencil beams of proton, 4He and 12C ions were used to irradiate spherical phantoms of 40 
cm diameter, with the beam axis crossing the centre of the phantom (see Figure 1). The size of the phantom was chosen to represent 
the size of a human abdomen, and for simplicity, a spherical shape is used. The energy deposited in the phantom was calculated 
along the direction of incidence of the beam (z-axis) so to obtain particle depth dose curves. The bin size of the depth dose profile 
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is 1 mm. The energy deposited along the x-axis at the position of the BP, for a longitudinal width of 10 mm, was also calculated. 
Proton and 4He beams of 62, 150, 200 and 250 MeV/u, and 12C beams of 120, 285, 385 and 490 MeV/u were simulated. From our 
simulation results, these energies correspond to ranges (80% distal dose fall-off) of approximately 30, 160, 260 and 380 mm in 
water. The beam range values are consistent with NIST [41] for proton/helium ions and SRIM [42] for carbon ions taking into 
account that they calculate the ranges with the continuous slowing down approximation (CSDA) and projected range algorithm 
(PRAL), respectively. These energy ranges were chosen as they are typical of therapy treatment for the respective particle types 
with the exception of the energies 250 MeV/u of 4He and 490 MeV/u of 12C, which were also included for comparison. The number 
of incident particles was 108 for protons, 107 for 4He ions and 106 for 12C ions to obtain a statistical uncertainty of 5% in the yield 
of PG rays. The statistical uncertainty was calculated with 1/√𝑁, where 𝑁 is the number of counts. Uncertainties that affect physics 
concepts are not taken into account, the uncertainties are purely statistical. An air-filled idealized detecting sphere surface (called 
detection sphere), with 100 cm diameter encompassing the phantom, was used to score the gamma rays and neutrons reaching its 
surface once emitted from the phantom. Characterization of the gamma/neutron radiation field using the detection sphere provides 
beneficial information which assists in choosing potential PG detectors. As the BP position within the phantom varies with particle 
beam energy, a fixed point of reference was chosen at the surface of the phantom, which is similar to a fixed point on the patient 
surface in the clinical setting. Hence, the simulation coordinate centre was fixed at the surface of the phantom and at the centre of 
the detection sphere. 
A modularized Geant4 Physics List was used which included both electromagnetic (G4EmStandardPhysics_option3) and 
hadronic physics (QGSP_BIC_HP). The G4RadioactiveDecayPhysics and G4HadronElasticPhysicsHP modules were active. The 
QGSP_BIC_HP was chosen as it was found adequate for proton and carbon therapy studies in [43,44]. Total cross sections are 
described by the Glauber-Gribov theory [45] and the final state of inelastic scattering is generated by the Binary Cascade model 
[46]. The High Precision Neutron Data Libraries were used to more accurately model the neutron interactions from thermal energies 
up to 20 MeV. Recent efforts to assess and improve the accuracy of prompt gamma productions in Geant4 physics for HT have 
been reported [47,48]. 
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(a)                           (b) 
Figure 1 (a) Geometrical simulation setup of the spherical water phantom in an air-filled detection sphere. (b) The angle  is formed from the longitudinal beam 
direction (z-axis) with the centre of the coordinate system at the phantom surface. P is the PG detection position on the detection sphere traversed by the photons, 
and  is the azimuthal angle. 
 
The output of the simulation consisted of the emission yield of the secondary photons and neutrons when they originate in the 
phantom, and when they reach the detection sphere. The emission yield was normalized to the number of incident particles on the 
phantom. The PG emission time was calculated as the time interval between the origin of the primary particle in the simulation 
and the time of origin of the PG ray in the phantom. The PG detection time, defined as TOF, was calculated as the time interval 
between the origin of the primary particle in the simulation and the time when the PG ray reaches the detection sphere. The gamma 
TOF distribution mean and integral were retrieved from the simulation. 
In the post-simulation data analysis, several parameters of PG emission and detection were investigated. Table 1 lists these 
variables and their definition in this study. 
Table 1. Variables and definitions. 
Variable Definition 
R Particle beam range, defined as the position with 80% BP distal fall-off along the beam path in the phantom 
RPG PG range, defined as the position with 80% PG emission yield fall-off in the phantom 
 fall-off The difference R-RPG, used to quantify the longitudinal correlation between the PG emission and the beam range 
 FWHM The difference between the lateral PG emission distribution FWHM and lateral dose distribution FWHM for a 
10 mm longitudinal thickness at the BP position 
TPG The 80% fall-off of the PG emission time distribution 
TW The time difference between 80% rise and fall-off of the TOF spectra peak 
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In considering a point-of-reference in clinical conditions, the centre of the simulation coordinate system was fixed at the surface 
of the phantom, corresponding to the point of beam incidence. The angular emission characteristics of PG rays were studied with 
the polar angle  formed from the longitudinal beam direction (z-axis) with the point-of-reference (see Figure 1 (b)). The polar 
angle allows one to explore PG emission and propagation in the phantom and investigate a potential preferential position defined 
with respect to the surface of the phantom, where to locate the detector/s to maximize the number of detected PG rays. 
All photons generated in the water phantom, via any physical interaction process, were retrieved by the simulation. The energy 
spectrum of these photons allowed the observation of the prominent PG emission lines and the selection of two energy windows 
to study their yield and spatial correlation with respect to the BP, and their temporal and detection properties. The first energy 
selection had a threshold of ≥1 MeV, which eliminates the low-energy background photon counts [49], and the second had a 3.0-
7.0 MeV window, which includes the prominent PG emission lines and has been employed in previous studies [50,51]. The primary 
PG rays are referred to those produced from the primary particle beam interactions, and the secondary PG rays are referred to those 
produced from the interactions of the secondary radiation field. In addition, when calculating the PG emission yield to deposited 
energy ratio for the different ion species, we take the energy deposited and scored at the BP maximum. 
 
3. Results 
3.1 Energy spectra of prompt gamma emission within the water phantom 
Figure 2 shows the energy spectra of photons that originate in the water phantom from any physical interaction (including 
gamma photons induced by neutrons) for the three beam particle types. In each case the energy spectra show a consistent shape 
over a wide energy range, with several characteristic emission lines produced by non-elastic particle-nuclei interactions with major 
constituent elements of the phantom material. A peak at 0.511 MeV originates from the annihilation of positrons resulting from 
the decay of 15O and 11C nuclei among other isotopes that are also produced and contribute to this peak. The 2.22 MeV peak is a 
result of secondary thermal neutron capture by hydrogen nuclei. A 2.3 MeV peak arises from 14N by proton and alpha spallation 
reactions with 16O [52], which may be difficult for a detector to resolve from the 2.22 MeV neutron capture line. The prominent 
PG emission lines are observed with energy 4.44, 5.21 and 6.13 MeV, which are the most adopted PG rays for beam range 
verification. The 4.44 MeV PG emission line originates from the de-excitation of 12C* nuclei, derived from particle nuclear 
interactions with oxygen nuclei. The 5.21 and 6.13 MeV PG emission lines arise from 15O* and 16O* de-excitations, respectively. 
The intensity of the 2.3 MeV peak is comparable to the 4.44, 5.21 and 6.13 MeV peaks, however it could be challenging to detect 
since the 2.3 MeV line could be merged with the neutron capture line and detection will depend on the energy resolution of the 
detector. Hence, for this study we keep an energy window option for PG selection from 3.0 to 7.0 MeV, since it contains the most 
adopted PG emission lines for range verification for potential comparison purposes, as well as containing the 6.13 MeV line from 
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oxygen which is the most abundant element in the human body. In addition, the energy threshold of ≥1 MeV eliminates background 
photon counts, particularly those resulting from positron annihilation. The potential utilizable PG line at 0.718 MeV was not 
included in our simulation since it may be difficult to resolve in some detectors, such as LYSO detectors, where detector intrinsic 
radioactivity may interfere with the PG signal. 
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Figure 2. Energy spectra of photons generated in the water phantom deriving from pencil beams of protons, 4He and 12C ions. The emission lines are characteristic 
to the major constituent elements of the phantom material. The distinctive PG emission lines of energy 4.44, 5.21 and 6.13 MeV result from 12C, 15O and 16O nuclear 
de-excitations, respectively. 
 
3.2 Spatial correlation between prompt gamma emission and the particle beam range 
Figure 3 shows the longitudinal and lateral distribution of gamma rays produced in the phantom. The Bragg curve (for ~16 cm 
range) is plotted with the longitudinal distribution to show the correlation between the gamma emission and the dose deposition. 
It can be observed that the primary PG profile shows the closest correlating relationship to the beam range regarding the sharpness 
and fall-off in the BP region, which can provide reliable BP tracking in HT. The secondary PG profile shows a broad distribution 
with a long tail beyond the BP downstream, which could cause significant interference on the BP tracking. The secondary PG 
productions become more dominant in heavier ions (helium and carbon) than that in proton beams. In the PG emission of 4He and 
12C a discontinuity can been seen, which may be due to the transition to the precompound model at low energy nuclear reactions. 
The transition between high- and low-energy nuclear reaction models occurs at around 140 mm for 4He and at around 160 mm for 
12C. The lateral spreads of PG emissions are broader with increasing beam energies. The heavier ion beam (carbon) shows narrower 
lateral spread of PG emissions than the proton beam. This trend is consistent with that in their lateral dose spreads. 
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Figure 3. Left: Longitudinal yield distribution of total, primary and secondary gamma rays ≥1 MeV originating in the water phantom for protons (150 MeV), 4He 
(150 MeV/u) and 12C (285 MeV/u) ions. The percent depth dose is normalized to the dose maximum at the Bragg Peak. Right: Lateral yield distribution of total 
gamma rays ≥1 MeV for a longitudinal width of 10 mm at the BP positions for each of the beam energies. 
 
Table 2 presents data for the particle range and corresponding PG range for the applied energy threshold and window, for each 
incident particle type and energy under investigation. The quantified longitudinal difference,  fall-off, shows that the PG rays 
within 3.0-7.0 MeV offer better correlation to the beam range, particularly in the case of incident protons. For a particle range at 
16 cm depth, the  fall-off values are (-5.1 ± 0.5) mm, (+0.2 ± 0.5) mm and (+0.3 ± 0.5) mm, for proton, 4He and 12C ions, 
respectively. Negative  fall-off values indicate that the PG range is upstream of the particle range, while positive values indicate 
downstream of the particle range. However, the energy window offers the lowest gamma statistical yield (see Table 3). Instead the 
threshold of gamma rays ≥1 MeV, which eliminates low-energy background counts while incorporating the prominent PG rays, 
offers a good PG-BP position correlation with the benefit of a higher yield. It can be seen that for helium and carbon ions the 
variation of accuracy ( fall-off) is relatively small across the particle beam energies, independently from the gamma energy 
 
10 
 
windows, with an improved accuracy in estimating the beam range for these heavier ions with respect to incident protons. The 
quantified difference,  FWHM, shows that there is good conformity between the lateral PG production and dose deposition. 
 
Table 2. Particle beam range and corresponding PG range for the applied energy threshold and window studied, for each particle beam type and 
energy. The  fall-off and  FWHM, defined in Section 2, are reported for quantitative evaluation. 
Particle 
Type 
Beam 
Energy  
(MeV/u) 
Gamma Energy 
Selection 
(MeV) 
Longitudinal 
Beam Range 
(±0.5 mm) 
Longitudinal 
PG Range 
(±0.1 mm) 
 fall-off * 
(±0.5 mm) 
Lateral 
Dose FWHM 
(±0.2 mm) 
Lateral 
PG FWHM 
(±0.2 mm) 
 FWHM 
(±0.3 mm) 
Proton 62 
 
150 
 
200 
 
250 
≥1 
3.0-7.0 
≥1 
3.0-7.0 
≥1 
3.0-7.0 
≥1 
3.0-7.0 
31.9 
 
155.5 
 
256.3 
 
374.7 
 
27.0 
27.2 
150.2 
150.4 
250.8 
251.4 
368.2 
369.6 
-4.9 
-4.7 
-5.3 
-5.1 
-5.5 
-4.9 
-6.2 
-5.1 
1.2 
 
7.1 
 
11.9 
 
17.5 
 
1.0 
1.0 
6.7 
6.7 
11.8 
11.4 
16.4 
16.6 
0.2 
0.2 
0.4 
0.4 
0.1 
0.5 
1.1 
0.9 
4He 62 
 
150 
 
200 
 
250 
≥1 
3.0-7.0 
≥1 
3.0-7.0 
≥1 
3.0-7.0 
≥1 
3.0-7.0 
32.2 
 
156.6 
 
258.2 
 
377.4 
 
31.8 
32.0 
156.6 
156.8 
258.3 
258.4 
377.4 
377.4 
-0.4 
-0.2 
0. 
+0.2 
+0.1 
+0.2 
0. 
0. 
0.7 
 
3.5 
 
5.9 
 
8.5 
 
0.6 
0.6 
3.6 
3.5 
6.3 
6.1 
9.0 
9.4 
0.1 
0.1 
0.1 
0. 
0.4 
0.2 
0.5 
0.9 
12C 120 
 
285 
 
385 
 
490 
≥1 
3.0-7.0 
≥1 
3.0-7.0 
≥1 
3.0-7.0 
≥1 
3.0-7.0 
35.2 
 
157.3 
 
257.5 
 
377.7 
 
35.5 
35.4 
157.8 
157.6 
258.7 
258.3 
378.7 
378.6 
+0.3 
+0.2 
+0.5 
+0.3 
+1.2 
+0.8 
+1.0 
+0.9 
0.3 
 
1.9 
 
3.1 
 
4.5 
 
0.4 
0.4 
2.0 
1.8 
3.4 
3.3 
5.2 
4.8 
0.1 
0.1 
0.1 
0.1 
0.3 
0.2 
0.7 
0.3 
* Negative values indicate that the PG range is upstream of the particle range, while positive values indicate downstream of the particle range. 
 
3.3 Prompt gamma emission and detectable yield 
The yield values of PG rays originating in the spherical water phantom per incident particle are estimated and listed in Table 3. 
In the same table, the yields of PG rays reaching the detection sphere are reported. For each beam type, the PG emission yield 
increases with greater particle energy, as expected. The 12C beam produces the highest yield of gamma emission compared to the 
proton and 4He beams, with a relatively larger yield of low-energy photon counts. For example, comparing the beam types with 
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the same range of about 16 cm, the total gamma yield per incident particle is 0.87 for 150 MeV protons, 2.60 for 150 MeV/u 4He 
ions and 17.35 for 285 MeV/u 12C ions, while the yield for PG rays within 3.0-7.0 MeV is 0.07, 0.22 and 0.62, respectively. This 
gives a ratio of total gamma to PG of 12.4, 11.8 and 28.0 for proton, 4He and 12C, respectively. In other words, for 150 MeV protons 
the energy deposited at the BP maximum is ~3 MeV/ion, with a PG yield of ~7x10-4 /ion, which corresponds to ~2x10-4 PG rays 
emitted per MeV deposited energy at the BP. For 150 MeV/u 4He ions the energy deposited at the BP maximum is ~13 MeV/ion, 
with a PG yield of ~1x10-3 /ion, and ~8x10-5 PG/MeV at the BP. For 285 MeV/u 12C ions the energy deposited at the BP maximum 
is ~69 MeV/ion, with a PG yield of ~4x10-3 /ion, and ~6x10-5 PG/MeV at the BP. 
As expected, the detectable photon yield is less than the emission yield, since the gamma rays interact within the water phantom 
and can eventually be absorbed. The detectable PG (3.0-7.0 MeV) yield on the detection sphere is found to be around 65%. Again, 
the results show that the 12C beam produces a higher yield of detectable PG rays per incident ion compared to the proton and 4He 
beams. The PG yield, between 3.0-7.0 MeV, per incident particle for the beams with around 16 cm range is 0.05 for protons (150 
MeV), 0.14 for 4He (150 MeV/u) ions and 0.40 for 12C (285 MeV/u) ions. 
 
Table 3. Yield values of gamma photons originating within the water phantom and those reaching the detection sphere once emitted from the 
phantom. The simulation statistical uncertainty is within 5%. 
Particle Type 
Particle Beam Energy  
(MeV/u) 
Gamma Energy Selection 
(MeV) 
Gamma Yield Per Incident Particle 
In Phantom Detection Sphere 
Proton 62 
 
 
150 
 
 
200 
 
 
250 
No window 
≥1 
3.0-7.0 
No window 
≥1 
3.0-7.0 
No window 
≥1 
3.0-7.0 
No window 
≥1 
3.0-7.0 
0.19 
0.03 
0.02 
0.87 
0.13 
0.07 
1.40 
0.20 
0.10 
1.95 
0.27 
0.13 
0.06 
0.02 
0.01 
0.25 
0.09 
0.05 
0.39 
0.14 
0.07 
0.53 
0.19 
0.09 
4He 62 
 
 
150 
 
 
200 
 
No window 
≥1 
3.0-7.0 
No window 
≥1 
3.0-7.0 
No window 
≥1 
0.41 
0.10 
0.05 
2.60 
0.54 
0.22 
4.00 
0.77 
0.17 
0.08 
0.04 
0.86 
0.36 
0.14 
1.25 
0.51 
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250 
3.0-7.0 
No window 
≥1 
3.0-7.0 
0.32 
5.20 
0.90 
0.38 
0.20 
1.55 
0.61 
0.25 
12C 120 
 
 
285 
 
 
385 
 
 
490 
No window 
≥1 
3.0-7.0 
No window 
≥1 
3.0-7.0 
No window 
≥1 
3.0-7.0 
No window 
≥1 
3.0-7.0 
3.91 
0.32 
0.15 
17.35 
1.42 
0.62 
25.02 
2.00 
0.86 
30.40 
2.44 
1.01 
0.73 
0.23 
0.10 
2.94 
0.95 
0.40 
4.25 
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3.4 Angular distribution for detectable prompt gamma 
Figure 4 shows the angular distributions of total gamma rays which reach the idealized detection sphere normalized per incident 
ion per steradian for proton, 4He and 12C beams for the different beam energies. At the low energies of 62 MeV/u (for both proton 
and helium beams) and 120 MeV/u (for carbon beam), the detectable gamma rays are slightly preferred backward in  = 100-180o. 
But at higher beam energies the detectable gamma emissions become more forward in  = 20-40o. In addition, such forwardness 
increases with the heavier ion species. With increasing depth of the BP position as the beam energy increases, the favorable PG 
detection is likely to be increasingly forward. Further analysis of proton irradiations with respect to the BP position can be found 
in our previous study [53]. 
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Figure 4. Angular distribution of total gamma rays reaching the idealized detecting sphere normalized per incident ion per steradian for the lower two beam energies 
(left) and the higher two beam energies (right) for protons, 4He and 12C ions. 
 
3.5 Temporal characteristics of prompt gamma emission and detection: relationship with the particle beam range 
The timing distribution of PG emission varies with particle beam energy as expected, since the beam range/transit time also 
increases and so gamma rays are produced at greater depths in the phantom and hence at later time. Figure 5 shows the emission 
time distribution of total gamma rays and those ≥1 MeV for each particle type and energy. The PG emission time profiles with 
applied gamma energy threshold of 1 MeV show a clear fall-off which is linked to the BP fall-off in the dose profile. The PG 
emission time TPG (defined in Section 2) for gamma rays ≥1 MeV is (2.5 ± 0.1) ns, (2.7 ± 0.1) ns and (1.9 ± 0.1) ns for protons, 
4He and 12C ions with a range of around 38 cm. The emission time of gamma rays from carbon ions is seen to be quicker than that 
of proton and helium ions; this may be due to the carbon ions moving at greater speed as they traverse the phantom. 
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Figure 5. Emission time distribution of total gamma rays (left) and gamma rays ≥1 MeV (right) originating in the phantom for protons, 4He and 12C ions. The bin 
width is 0.01 ns. 
 
Figure 6 shows the TOF spectra of total gamma rays, neutrons and gamma rays ≥1 MeV that reach the detection sphere once 
emitted from the phantom. As the beam energy increases, the PG TOF peak mean is seen to shift to longer TOF values while the 
peak width/integral increases. Again, this is attributed to the greater distance of travel by the ions in the phantom. For proton 
beams, neutrons are not predominantly detected until around 3 ns, which could suggest another means of discriminating PG rays 
from the background and hence improve the signal-to-background ratio of PG detection. This may be slightly more difficult for 
heavier ions helium and carbon particularly at high beam energies, for which there is a greater presence of neutron emission and 
temporal overlap between PG and neutrons. 
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Figure 6. TOF spectra of total gamma and neutrons (left) and gamma rays ≥1 MeV (right) reaching the detection sphere once emitted from the phantom for protons, 
4He and 12C ions. The bin width is 0.1 ns. 
 
Figure 7 shows 2D representations of the TOF spectra of primary gamma rays along the polar angle  for proton, 4He and 12C 
beams at each of the beam energies studied, respectively. Figure 8 shows the same data for primary gamma rays ≥1 MeV. PG 
detection is seen to be increasingly forward-peaked, with respect to the phantom surface, with increasing beam energy for each 
particle beam type, as observed also in Figure 4. In addition, the TOF width increases and its maximum shifts to longer time values, 
particularly for proton and helium ions, whereas the TOF data for carbon irradiations shows less widening/shift in the distribution 
with greater local increase in PG yield. With additionally applying an energy threshold of 1 MeV to the primary gamma rays 
reaching the idealized detecting sphere, the TOF tail is seen to be almost entirely eliminated, leaving only the highly localized TOF 
peak. 
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Figure 7. TOF spectra along the polar angle  of primary gamma rays reaching the detection sphere once emitted from the phantom for protons, 4He and 12C ions. 
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Figure 8. TOF spectra along the polar angle  of primary gamma rays ≥1 MeV reaching the detection sphere once emitted from the phantom for protons, 4He and 
12C ions. 
 
Figure 9 shows the particle beam range plotted against the PG range RPG and PG emission time TPG, as well as PG TOF data 
(peak mean, width and integral) for each particle type and energy studied. The PG data are those above the energy threshold of 1 
MeV. As also seen in Section 3.2, the PG range offers good correlation with the particle range. TPG values show a linear increase 
with beam energy, as the emission time of PG rays is correlated to the beam transit time and thus beam range. For a global detection 
setup, the PG TOF peak mean and width are found to only slightly increase with beam energy, with a minor drop in the case of 
carbon ions at higher energies. On the other hand, the PG TOF peak integral values exhibit a greater linear increase with particle 
beam energy. 
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Figure 9. Quantitative comparison of the particle beam range with PG emission and detection data, for protons (top), 4He (centre) and 12C (bottom) ions. Left: 
Particle beam range and corresponding PG range RPG, with PG emission time TPG. The dotted line joining the particle range values serves to guide the eye. Right: 
PG TOF peak mean, width and integral. All PG data are for gamma rays ≥1 MeV. The uncertainty in the beam range is 0.5 mm, PG range is 0.1 mm, emission 
time/TOF mean is 0.1 ns, and TOF width is 0.2 ns. 
 
4. Discussion 
In this work, the PG emission characteristics in the aspects of space, energy and time were investigated using Geant4 simulations 
with a water phantom irradiated with three different particle types: protons, 4He and 12C ions of varying energy. The PG production 
and detectable yields, energy spectral, spatial and temporal correlation characteristics with the depth dose profile were quantified. 
A relatively low energy threshold of 1 MeV for PG selection was used in this study to ensure higher statistics. For comparison, the 
PG energy window of 3.0-7.0 MeV adopted in other studies [50,51] was also included in our study. 
Our results show that the primary PG emissions from the beam’s nuclear interactions exhibit the closest correlation to the depth 
dose profile with sharp fall-off in the BP region, which is best suited for BP tracking in HT. The PG-BP correlations are better for 
heavier ions 4He and 12C than proton beams. The largest fall-off differences of PG production (comparing the applied energy 
selections) and the BP was found to be (6.2 ± 0.5) mm for protons, (0.4 ± 0.5) mm for 4He and (1.2 ± 0.5) mm for 12C ions. A 
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consistent correlation in the lateral spreads between the PG emission and dose deposition is also observed in our study. These 
indicate that the PG signal is a reliable means for in vivo beam range verification and dose monitoring in HT. However, the 
measurable PG signal is largely masked by the concurrent emission of secondary PG rays resulting from the nuclear reactions 
undergone by the secondary particles/fragments created along the primary ion beam path since the primary PG and the secondary 
PG are not quite differentiable in experimental measurements. The secondary PG emissions with broad distribution and long tail 
beyond the BP region become more dominant in heavier ions (helium and carbon) than that in proton beams. This indicates that 
employing PG rays for range verification in carbon therapy presents more challenges. 
With the use of an idealized detection sphere, the global angular distribution of detectable PG rays was investigated, for each 
particle type and energy studied. The observed non-isotropic longitudinal distribution of the detectable PG rays is likely due to the 
kinematics of the nuclear reactions. The default cascade model of Geant4 physics was used in our simulation study, which does 
not take angular momentum coupling of the gamma quanta emitted in a cascade into account. Further investigation is required to 
determine the influence of activating angular momentum coupling on the angular distribution. Attenuation/absorption of gamma 
rays within the phantom was taken into account in our simulation. So the geometric effect, such as the phantom shape and size, 
also play a role in the angular variances seen on the idealized detecting sphere. In replacing the sphere phantom with a box and 
cylinder phantom, we have observed that the shape of the phantom does have a considerable effect on the angular distribution due 
to attenuation/absorption. Additionally, since the target is not in the centre of the detection sphere, this introduces a dependency 
from the origin of the PG rays with 1/𝑟2. These factors may be the reasons that our results of angular distribution are different to 
the experimental data in [23]. Hence, further study of the factors influencing the angular distribution of the detectable PG rays is 
necessary. 
In addition to the changing angular distribution, the TOF distribution of gamma rays reaching the detection sphere also varies; 
the width and integral increase while the peak mean shifts to longer time values, which are also attributed by the greater distance 
of travel by the ions in the phantom. For primary gamma rays reaching the detecting sphere these angular/TOF properties are also 
seen, and with additionally applying an energy threshold of 1 MeV to the primary gamma rays, the TOF tail becomes almost 
entirely eliminated, leaving only the highly localized TOF peak. The detectable yield of high-energy PG rays was found to be 
about 65-70%. An important issue is whether there is enough PG statistics for spot tracking in PBS of HT. Considering a typical 
PBS proton beam with a rate of 108 protons per second and a spot duration of about 20 ms, each spot will have 2x106 incident 
protons. If we consider our simulated beam incidence as a single spot, for 2x106 incident protons at 150 MeV the total detectable 
PG yield at energy ≥1 MeV on the idealized detecting sphere would be ~1.8x105 with a production yield of ~2.6x105 within the 
water phantom. Considering a 5x5 cm2 detector size on the simulated sphere the detectable PG counts are ~3x102, yielding a 
statistical error of about 6%. This implies that spot by spot monitoring using PG rays for this particular beam 
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energy/geometry/detector size is a challenge in terms of obtaining sufficient statistics for clinical applications in HT. As mentioned 
by Krimmer et al 2018 [19], the statistics can be increased by accumulating the information from several beam spots when they 
correspond to the same expected range, but at the expense of spatial resolution. In comparison, our results show that 12C ions 
provide a higher PG yield; for 2x106 incident ions, which corresponds to around 69 MeV/ion deposited energy at the BP position, 
at 285 MeV/u the detectable PG counts are ~3x103 on a 5x5 cm2 detector size. Similarly, for 2x106 incident 4He ions at 150 MeV/u 
the detectable PG counts on a 5x5 cm2 area is ~1x103. 
The temporal characteristics of PG rays were also studied in terms of the PG emission time within the phantom and PG detection 
time at the idealized detecting sphere, with the beam incidence marking the start time. The PG emission time is associated with the 
beam transit time which is closely correlated to the depth of beam interaction in matter. So the beam range can be extracted from 
the measured TOF spectrum of PG rays as well. The PGT [35] method retrieves the beam range by means of the TOF peak’s mean 
and width while the PGPI [36] method makes use of the integral counts of the TOF spectrum to extract the beam range. With the 
idealized detection sphere, the obtained PG TOF spectrum is most likely to reflect the intrinsic characteristics of the PG TOF 
spectroscopy from the phantom. The realistic PG TOF spectrum in experimental measurements could be much more complicated 
and it largely depends on the nature of the delivered beam time structure and also the detector’s time resolution [54]. The very 
narrow time range of PG TOF in a few nanoseconds implies that ultra-high time resolution of the detector (<1 ns) is required in 
order to accurately extract the range information from the measured PG TOF spectroscopy. In addition, the good separation in the 
TOF characteristics between PG rays and neutrons can be utilized to discriminate the PG signal from the neutrons and neutron-
associated backgrounds. This has been proposed by Testa et al 2008 [55] for 12C ions at low energies where the radiofrequency 
(RF) signal of the accelerator at the GANIL facility could be used as the start time reference. However, this technique is not suitable 
for synchrotron facilities, where instead a trigger signal from a fast transmission detector may be used. Biegun et al 2012 [56] used 
Monte Carlo simulations to investigate the TOF neutron rejection technique for protons. Hueso-González et al 2018 [37] performed 
experimental measurements of the technique for protons accelerated by cyclotrons. However, the application of TOF for proton, 
4He and 12C ions in synchrotron facilities at clinical energies and intensities has not yet been demonstrated experimentally. As 
pointed out in [19], TOF may be inefficient for PG detection in proton therapy with synchrotrons due to long bunch times, while 
for carbon therapy the detection of individual ion impacts may be possible at mean intensities of 107-108 ions/second by means of 
fast beam hodoscopes. Combining the TOF and angular preference of PG detections could further improve the signal-to-
background ratio for PG measurements. 
 
5. Conclusion 
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The PG signal is a reliable means for in vivo range verification via BP tracking in HT. The primary PG rays exhibit the closest 
correlation to the beam range but it is masked by the concurrent secondary PG rays. The dominant secondary PG rays in heavier 
ions such as carbon beams impose greater challenges for BP tracking from the PG profile. The investigation into the angular 
distribution of PG rays showed a changing angular propagation distribution with beam energy, which may suggest that a movable 
PG detector coordinated with respect to the beam range could serve to optimize the detection efficiency of PG rays. The influence 
of activating angular momentum coupling on the angular distribution has not been investigated in this study but we will quantify 
the coupling effect in the next stage of this work. The PG TOF spectroscopy encodes the essential information of the beam range 
but needs high time resolution measurements to retrieve it. Hybrid PG detection systems to utilize the energy, timing and spatial 
characteristics of PG rays is desirable for BP tracking in real-time. 
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